Showing results (61-70 of 424) with videos related to
Sort By:
Pageof 43
Trends in Cancer|June 17, 2020
Clinical Development of BRAF plus MEK Inhibitor CombinationsVivek Subbiah, Christina Baik, John M KirkwoodJCO Oncology Practice|May 13, 2024
Ready, Set, Go: Setting Off on the Mission to Target KRAS in Colorectal CancerAndrew J Pellatt, Deepak Bhamidipati, Vivek SubbiahExpert Opinion on Investigational Drugs|September 23, 2011
Insulin-like growth factor 1 receptor (IGF-1R) inhibitor: another arrow in the quiver - Will it hit the moving target?Vivek Subbiah, Laura S Angelo, Razelle KurzrockCancer|November 7, 2023
Revolutionizing cancer drug development: Harnessing the potential of basket trialsVivek Subbiah, Howard A Burris, Razelle KurzrockJournal of Personalized Medicine|February 26, 2026
Molecular-Guided Precision Oncology in Cancer of Unknown Primary: A State-of-the-Art PerspectiveVivek Subbiah, Elie Rassy, Frank A GrecoSaudi Medical Journal|August 30, 2016
Research output of Arab students. The way forwardYassar Alamri, Omar A Aboshady, Mohamed A GoudaJournal of Breast Cancer|October 17, 2014
Combined Antiangiogenic and Mammalian Target of Rapamycin Inhibitor Targeted Therapy in Metaplastic Breast Cancer Harboring a PIK3CA MutationRishi Agarwal, Kimberly Koenig, Eric Rohren, et al.Orphanet Journal of Rare Diseases|July 31, 2013
Comprehensive characterization of malignant phyllodes tumor by whole genomic and proteomic analysis: biological implications for targeted therapy opportunitiesDenis L Fontes Jardim, Anthony Conley, Vivek SubbiahDiscovery Medicine|January 30, 2019
Bringing wearable devices into oncology practice: fitting smart technology in the clinicArjun K Menta, Ishwaria M Subbiah, Vivek SubbiahBMJ Case Reports|November 20, 2015
Radium-223 dichloride therapy in breast cancer with osseous metastasesAmol Takalkar, Bhavna Paryani, Scott Adams, et al.Pageof 43